These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery. Rosati E; Pogorelyy MV; Minervina AA; Scheffold A; Franke A; Bacher P; Thomas PG bioRxiv; 2021 Nov; ():. PubMed ID: 34845450 [TBL] [Abstract][Full Text] [Related]
3. Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination. Mosavie M; Rynne J; Fish M; Smith P; Jennings A; Singh S; Millar J; Harvala H; Mora A; Kaloyirou F; Griffiths A; Hopkins V; Washington C; Estcourt LJ; Roberts D; Shankar-Hari M Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340069 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-specific T cells exhibit unique features reflecting robust helper function, lack of terminal differentiation, and high proliferative potential. Neidleman J; Luo X; Frouard J; Xie G; Gill G; Stein ES; McGregor M; Ma T; George A; Kosters A; Greene WC; Vasquez J; Ghosn E; Lee S; Roan NR bioRxiv; 2020 Aug; ():. PubMed ID: 32577663 [TBL] [Abstract][Full Text] [Related]
9. Understanding the T cell immune response in SARS coronavirus infection. Janice Oh HL; Ken-En Gan S; Bertoletti A; Tan YJ Emerg Microbes Infect; 2012 Sep; 1(9):e23. PubMed ID: 26038429 [TBL] [Abstract][Full Text] [Related]
10. Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans. Spensieri F; Siena E; Borgogni E; Zedda L; Cantisani R; Chiappini N; Schiavetti F; Rosa D; Castellino F; Montomoli E; Bodinham CL; Lewis DJ; Medini D; Bertholet S; Del Giudice G PLoS One; 2016; 11(6):e0157066. PubMed ID: 27336786 [TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients. Niu X; Li S; Li P; Pan W; Wang Q; Feng Y; Mo X; Yan Q; Ye X; Luo J; Qu L; Weber D; Byrne-Steele ML; Wang Z; Yu F; Li F; Myers RM; Lotze MT; Zhong N; Han J; Chen L Front Immunol; 2020; 11():633815. PubMed ID: 33408723 [TBL] [Abstract][Full Text] [Related]
12. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection. Khan F; van den Akker T; Hussein S; Marcellino BK; Khattar P; Glicksberg BS; Nadkarni GN; Firpo-Betancourt A; El Jamal SM J Hematop; 2020 Sep; 13(3):197-199. PubMed ID: 32837599 [No Abstract] [Full Text] [Related]
16. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444 [TBL] [Abstract][Full Text] [Related]
17. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Eschweiler S; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P Cell; 2020 Nov; 183(5):1340-1353.e16. PubMed ID: 33096020 [TBL] [Abstract][Full Text] [Related]
18. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Mateus J; Grifoni A; Tarke A; Sidney J; Ramirez SI; Dan JM; Burger ZC; Rawlings SA; Smith DM; Phillips E; Mallal S; Lammers M; Rubiro P; Quiambao L; Sutherland A; Yu ED; da Silva Antunes R; Greenbaum J; Frazier A; Markmann AJ; Premkumar L; de Silva A; Peters B; Crotty S; Sette A; Weiskopf D Science; 2020 Oct; 370(6512):89-94. PubMed ID: 32753554 [TBL] [Abstract][Full Text] [Related]